Product Information
AIMOVIG 70 MG/ML AUTOINJECTOR is a brand product labeled by Amgen Inc., priced at $753.5710 per ML under NDC 55513084101. Its NADAC has been published 420 times since Sep 19, 2018.
Strength
70 mg/mL
Manufacturer
Amgen Inc.NDC
55513084101
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ERENUMABApproval Type
Biologic (BLA)
FDA Application
BLA761077On Market Since
5/22/2018
Price Statistics
The NADAC for AIMOVIG 70 MG/ML AUTOINJECTOR has been published 420 times since Sep 19, 2018, and over the history we have for it it has risen 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $753.5710 per ML |
|---|---|
| All-time high | $753.7042 (Jul 15, 2026) |
| All-time low | $554.7674 (Jul 17, 2019) |
| 52-week high | $753.7042 |
| 52-week low | $738.5081 |
| Median price | $674.9358 |
| Average price | $661.3005 |
| Largest weekly change | +5.9% (Feb 3, 2021) |
| Weeks tracked | 420 |
| Tracking since | Sep 19, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the erenumab-aooe market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
erenumab-aooe market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AIMOVIG 70 MG/ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for AIMOVIG 70 MG/ML AUTOINJECTOR, manufactured by Amgen Inc., is $753.5710 per ML (NDC 55513084101), effective Sep 30, 2026.
How has the price of AIMOVIG 70 MG/ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for AIMOVIG 70 MG/ML AUTOINJECTOR has risen 35.2%. It has been tracked across 420 weekly CMS publications since Sep 19, 2018.
What are the highest and lowest recorded NADAC prices for AIMOVIG 70 MG/ML AUTOINJECTOR?
Since Sep 19, 2018, the NADAC for AIMOVIG 70 MG/ML AUTOINJECTOR has ranged from a low of $554.7674 (Jul 17, 2019) to a high of $753.7042 (Jul 15, 2026), with a median of $674.9358 per ML.
Are there cheaper alternatives to AIMOVIG 70 MG/ML AUTOINJECTOR?
No other NADAC-published product currently shares the active ingredient and strength of AIMOVIG 70 MG/ML AUTOINJECTOR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AIMOVIG 70 MG/ML AUTOINJECTOR?
AIMOVIG 70 MG/ML AUTOINJECTOR (NDC 55513084101) is labeled by Amgen Inc., and CMS classifies it as a brand product.